Skip to content

This content is in French.

Chagas: Is a vaccine finally within reach?

17 avril 2026

Chagas: Is a vaccine finally within reach?

By Ana Espino | Published on April 17, 2026 | 3 min readChagas disease is a parasitic infection caused by Trypanosoma cruzi, affecting approximately 6–7 million people worldwide, mainly in Latin America. It is characterized by an acute phase followed by a chronic infection that can last a lifetime and, in about 30% of patients, progress to severe cardiac or digestive complications. Current treatme

By Ana Espino | Published on April 17, 2026 | 3 min read


Chagas disease is a parasitic infection caused by Trypanosoma cruzi, affecting approximately 6–7 million people worldwide, mainly in Latin America. It is characterized by an acute phase followed by a chronic infection that can last a lifetime and, in about 30% of patients, progress to severe cardiac or digestive complications.

Current treatment options are limited to two drugs, benznidazole and nifurtimox, whose effectiveness is mainly demonstrated during the acute phase. Their efficacy declines significantly in the chronic phase, and their use is often limited by adverse effects. Moreover, no vaccine is currently available, representing a major gap in the fight against this disease.

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Teixeira SM, et al. The time has come for a vaccine against Chagas disease. Lancet Reg Health Am. 2025 Mar 21;45:101059. doi: 10.1016/j.lana.2025.101059. PMID: 40206818; PMCID: PMC11981767.

View on PubMed